We are live on ! Find out more
PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Portfolio holdings

AUM $73.6M
1-Year Est. Return 61.93%
This Fund
S&P 500
This Quarter Est. Return
-2.08%
1 Year Est. Return
+61.93%
3 Year Est. Return
+167.56%
5 Year Est. Return
+341.85%
10 Year Est. Return
+2,192.73%
AUM
$68.6M
AUM Growth
-$51.6M
Cap. Flow
-$49.3M
Cap. Flow %
-71.9%
Top 10 Hldgs %
85.81%
Holding
22
New
2
Increased
3
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$5.03M
2
JPM icon
JPMorgan Chase
JPM
+$4.53M
3
GDX icon
VanEck Gold Miners ETF
GDX
+$2.26M
4
HAIN icon
Hain Celestial
HAIN
+$727K
5
QADA
QAD Inc.
QADA
+$214K

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$13.3M
2
DAL icon
Delta Air Lines
DAL
+$11.2M
3
C icon
Citigroup
C
+$8.64M
4
MS icon
Morgan Stanley
MS
+$7.48M
5
OXY icon
Occidental Petroleum
OXY
+$4.2M

Sector Composition

Rank Sector Weight
1 Healthcare 34.26%
2 Energy 33.47%
3 Financials 12.31%
4 Technology 5.77%
5 Consumer Staples 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVGS icon
1
Navigator Holdings
NVGS
$1.26B
$12.4M 18.06%
1,055,000
-108,028
-9% -$1.24M
IRIX icon
2
IRIDEX
IRIX
$15.1M
$7.15M 10.42%
1,250,000
– –
AGN
3
DELISTED
Allergan plc
AGN
$6.73M 9.81%
40,000
+30,000
+300% +$5.03M
OXY icon
4
Occidental Petroleum
OXY
$58.5B
$5.85M 8.52%
90,000
-60,000
-40% -$4.2M
RETA
5
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$5.13M 7.47%
250,000
– –
PARR icon
6
Par Pacific Holdings
PARR
$3.9B
$4.72M 6.88%
275,000
-135,000
-33% -$2.44M
CDNA icon
7
CareDx
CDNA
$2.45B
$4.5M 6.56%
564,600
-383,400
-40% -$2.36M
JPM icon
8
JPMorgan Chase
JPM
$971B
$4.4M 6.41%
+40,000
New +$4.53M
C icon
9
Citigroup
C
$231B
$4.05M 5.9%
60,000
-115,000
-66% -$8.64M
QADA
10
DELISTED
QAD Inc.
QADA
$3.96M 5.77%
95,000
+5,000
+6% +$214K
ESXB
11
DELISTED
Community Bankers Trust Corporation
ESXB
$2.25M 3.28%
250,000
-32,648
-12% -$275K
GDX icon
12
VanEck Gold Miners ETF
GDX
$27.8B
$2.2M 3.2%
+100,000
New +$2.26M
HAIN icon
13
Hain Celestial
HAIN
$52.9M
$1.92M 2.8%
60,000
+20,000
+50% +$727K
HHH icon
14
Howard Hughes
HHH
$3.98B
$696K 1.01%
5,245
-15,735
-75% -$1.93M
TUES
15
DELISTED
Tuesday Morning Corp
TUES
$647K 0.94%
163,709
– –
DAL icon
16
Delta Air Lines
DAL
$59.1B
– –
-200,000
Closed -$11.2M
LUV icon
17
Southwest Airlines
LUV
$22B
– –
-50,000
Closed -$3.27M
MS icon
18
Morgan Stanley
MS
$342B
– –
-142,500
Closed -$7.48M
SPY icon
19
State Street SPDR S&P 500 ETF Trust
SPY
$809B
– –
-50,000
Closed -$13.3M
ZBH icon
20
Zimmer Biomet
ZBH
$18.7B
– –
-15,450
Closed -$1.81M
SGI
21
Somnigroup International
SGI
$13.5B
– –
-120,000
Closed -$1.88M

Similar funds

TWM
Tripletail Wealth Management Orlando, Florida $73.4M AUM 26.64% 1-Year Est. Return
JCA
January Capital Advisors San Francisco, California $74.2M AUM
WH
Wallace Hart Lexington, Kentucky $72.6M AUM 34.63% 1-Year Est. Return
WPA
Winning Points Advisors Boca Raton, Florida $74.8M AUM
PWS
Pursuit Wealth Strategies Raleigh, North Carolina $72M AUM
SPC
Square Peg Capital Surry Hills, NSW, Australia $75.2M AUM 15.62% 1-Year Est. Return
OC
Owlhouse Capital New York $75.3M AUM
IVMX
Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return

Paragon Associates & Paragon Associates II Joint Venture's Q1 2018 Portfolio in Review

As of Q1 2018, Paragon Associates & Paragon Associates II Joint Venture held 22 positions worth $68.6M, down 43% from $120M the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Paragon Associates & Paragon Associates II Joint Venture withdrew a net $49.3M in Q1 2018, closing 6 positions and reducing 7 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 22% a quarter earlier, followed by Energy and Financials.

Against the trend, Paragon Associates & Paragon Associates II Joint Venture opened a new position in JPMorgan Chase worth $4.4M.

  • Paragon Associates & Paragon Associates II Joint Venture's largest Q1 2018 buy was JPMorgan Chase: 40,000 shares worth $4.4M.
  • Paragon Associates & Paragon Associates II Joint Venture added most to Allergan plc in Q1 2018, an estimated $5.03M increase.
  • Paragon Associates & Paragon Associates II Joint Venture's biggest Q1 2018 reduction was Citigroup, cutting an estimated $8.64M.
  • Paragon Associates & Paragon Associates II Joint Venture fully exited State Street SPDR S&P 500 ETF Trust in Q1 2018, selling an estimated $13.3M.
  • Paragon Associates & Paragon Associates II Joint Venture's ten largest holdings make up 86% of its $68.6M portfolio in Q1 2018.
  • Paragon Associates & Paragon Associates II Joint Venture opened 2 new positions and closed 6 in Q1 2018.
  • Paragon Associates & Paragon Associates II Joint Venture's portfolio value fell 43% quarter-over-quarter to $68.6M.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q1 2018, filed 15 May 2018.